Showing results (31-40 of 59) with videos related to
Sort By:
Pageof 6
BMC Structural Biology|April 9, 2009
Characterization of conserved properties of hemagglutinin of H5N1 and human influenza viruses: possible consequences for therapy and infection controlVeljko Veljkovic, Nevena Veljkovic, Claude P Muller, et al.Plos One|November 10, 2016
Predicted Enhanced Human Propensity of Current Avian-Like H1N1 Swine Influenza Virus from ChinaVeljko Veljkovic, Nevena Veljkovic, Slobodan Paessler, et al.Frontiers in Microbiology|January 7, 2016
Evolution of 2014/15 H3N2 Influenza Viruses Circulating in US: Consequences for Vaccine Effectiveness and Possible New PandemicVeljko Veljkovic, Slobodan Paessler, Sanja Glisic, et al.Scientific Reports|June 20, 2015
In Silico Prediction and Experimental Confirmation of HA Residues Conferring Enhanced Human Receptor Specificity of H5N1 Influenza A VirusesSonja Schmier, Ahmed Mostafa, Thomas Haarmann, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|November 30, 2004
Antibodies reactive with C-terminus of the second conserved region of HIV-1gp120 as possible prognostic marker and therapeutic agent for HIV diseaseNevena Veljkovic, Donald R Branch, Radmila Metlas, et al.Chemistryopen|February 1, 2022
Identification of SARS-CoV-2 Papain-like Protease (PLpro) Inhibitors Using Combined Computational ApproachMilan Sencanski, Vladimir Perovic, Jelena Milicevic, et al.Expert Opinion on Drug Discovery|November 22, 2012
New in silico and conventional in vitro approaches to advance HIV drug discovery and designGiovanni Maga, Nevena Veljkovic, Emmanuele Crespan, et al.Antiviral Therapy|February 29, 2020
In vitro anti-influenza activity of in silico repurposed candidate drug cycrimineStanislava Matejin, Natalya Bukreyeva, Draginja Radosevic, et al.The Protein Journal|December 16, 2011
Assessment of hepatitis C virus protein sequences with regard to interferon/ribavirin combination therapy response in patients with HCV genotype 1bSanja Glisic, Nevena Veljkovic, Snezana Jovanovic Cupic, et al.F1000Research|July 14, 2015
In silico analysis suggests repurposing of ibuprofen for prevention and treatment of EBOLA virus diseaseVeljko Veljkovic, Marco Goeijenbier, Sanja Glisic, et al.Pageof 6